Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)

Roy Manning III

View Roy Manning III's StockTalks BY TICKER:
  • Roy Manning III
    SGYP may be a good buy right now. It raised 42m. Its constipation drug looks great. IRWD has a similar drug and It's valued at 1.3 billion.
    5/11/12
    Reply
      • Roy Manning III
        ARRY is a good buy. Expecting $20 million in milestone payments by end of year. Payments from partners keep this stock profitable.
        5/8/12
        Reply
          • Roy Manning III
            BCRX has sold off alot. I would consider it a buy now. News on a Gout drug partner or their Hep C. patent could push the stock higher.
            5/7/12
            Reply
              • Roy Manning III
                SCLN is up over 5% today. Check out my article.
                4/9/12
                Reply
                  • Roy Manning III
                    Working on an article on RNN. New focus on cancer drugs looks good to me. Possible partnership on Archexin when results come in Q3.
                    3/29/12
                    Reply (1)
                    • PAULNMYSTI: Thinking the same. This drug has blockbuster potential, since it will be the first of its kind in treating pancreatic cancer.
                      7/19/12
                      • Roy Manning III
                        Pozen has been adding a little each day. Maybe I was not wrong about the possible return on pos. study results.
                        3/29/12
                        Reply
                          • Roy Manning III
                            POZN price did not move much- it was only up 14% early in the day and ended the day up 8.75%. On a major study I expect 20-40%.
                            3/22/12
                            Reply
                              • Roy Manning III
                                POZN is up over 14% on positive results on their Ulcer Safe Aspirin. Look for further gains as they find a partner or buyout.
                                3/22/12
                                Reply
                                  • Roy Manning III
                                    NYMX continues to hold on as we wait for stage III trial to fill up. Offers a cure for Enlarged Prostate that works twice as well as pills.
                                    3/19/12
                                    Reply
                                      • Roy Manning III
                                        ZLCS-Zalicus value @100m 2b Synavive over 2h '12. Z160 for neuro pain starts stage 2in 2h '12. Z944 for acute pain soon stage2 watch Z160.
                                        3/18/12
                                        Reply
                                          • Roy Manning III
                                            POZN has $7 a share potential with Ulcer free aspirin study ending in march. Low cash burn since studies are over - $110m in cash.
                                            3/17/12
                                            Reply
                                              • Roy Manning III
                                                ATRS has be inching upwards. Look for this to continue as good results in Libigel trials continue to come in. AIS also has many other drugs.
                                                7/10/11
                                                Reply
                                                  • Roy Manning III
                                                    VICL has a new cancer vacine A-7. The final study results should be in by feb 2012 at the latest. If results are pos. the stock could go up.
                                                    7/10/11
                                                    Reply
                                                      • Roy Manning III
                                                        AEZS has a new colon cancer drug P. The final trial should show results this fall. If the results are good the stock should go higher.
                                                        7/10/11
                                                        Reply
                                                          • Roy Manning III
                                                            APRI has potential for its sexual drugs (male and female). Its been accepted in Canada and is applying for Euro which send it much higher.
                                                            7/10/11
                                                            Reply
                                                              • Roy Manning III
                                                                NYMX has begun to move. In my opinion this stock could be worth 10x current. Its leading drug offers a longterm cure for enlarged prostates
                                                                7/10/11
                                                                Reply
                                                                  • Roy Manning III
                                                                    SYN ; possible value play. Recent deal and pipeline all for $25 million market cap. Company finds and patents second uses for existing drugs
                                                                    6/4/10
                                                                    Reply
                                                                      • Roy Manning III
                                                                        SYN looks good. Recent partnership for a compound that will compete with Cymbalta. Zinc compound successfully tested for Alzeimers patients.
                                                                        5/15/10
                                                                        Reply
                                                                          • Roy Manning III
                                                                            CSUH - Celcius Holdings 1. unique product that burns 100 calories 2. market expanding rapidly to national 3. revenues should takeoff soon
                                                                            6/29/09
                                                                            Reply
                                                                              • Roy Manning III
                                                                                WNEA - Wind Energy America Inc. 1. recently installed wind turbines 2. gets stake in 3 windfarms in 2010 3. rapidly expanding in midwest
                                                                                6/27/09
                                                                                Reply